Activated PI3K-delta syndrome

Search Trials
Biomarker Identification in Orthopaedic & Oral Maxillofacial Surgery Subjects to Identify Risks of Bisphosphonate Use
Status:
Recruiting
Last Changed:
Jul 20, 2020
First Changed:
Jun 11, 2013
Disease(s):
Osteoporosis, With or Without Treatment
Evaluate Time Associated With the Preparation & Administration of Denosumab/Pamidronate in Patients With Solid Tumors and Metastatic Bone Disease
Status:
Withdrawn
Last Changed:
Feb 18, 2015
First Changed:
Apr 2, 2014
Disease(s):
Solid Tumor
Intervention(s):
denosumabpamidronate
Biomarker Identification in Orthopaedic & Oral Maxillofacial Surgery Subjects to Identify Risks of Bisphosphonate Use
Status:
Recruiting
Last Changed:
Jul 20, 2020
First Changed:
Jun 11, 2013
Disease(s):
Osteoporosis, With or Without Treatment
Evaluate Time Associated With the Preparation & Administration of Denosumab/Pamidronate in Patients With Solid Tumors and Metastatic Bone Disease
Status:
Withdrawn
Last Changed:
Feb 18, 2015
First Changed:
Apr 2, 2014
Disease(s):
Solid Tumor
Intervention(s):
denosumabpamidronate
Biomarker Identification in Orthopaedic & Oral Maxillofacial Surgery Subjects to Identify Risks of Bisphosphonate Use
Status:
Recruiting
Last Changed:
Jul 20, 2020
First Changed:
Jun 11, 2013
Disease(s):
Osteoporosis, With or Without Treatment

Connect. Empower. Inspire.